CERYOND Trademark

Trademark Overview


On Thursday, October 6, 2011, a trademark application was filed for CERYOND with the United States Patent and Trademark Office. The USPTO has given the CERYOND trademark a serial number of 85441117. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2014. This trademark is owned by Eli Lilly and Company. The CERYOND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
ceryond

General Information


Serial Number85441117
Word MarkCERYOND
Filing DateThursday, October 6, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 13, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, January 13, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 13, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2013EXTENSION 1 GRANTED
Wednesday, April 24, 2013EXTENSION 1 FILED
Tuesday, May 21, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 24, 2013TEAS EXTENSION RECEIVED
Tuesday, December 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 13, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 11, 2012ASSIGNED TO LIE
Thursday, August 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 6, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 6, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 8, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Sunday, January 8, 2012PRIORITY ACTION E-MAILED
Sunday, January 8, 2012PRIORITY ACTION WRITTEN
Tuesday, December 13, 2011ASSIGNED TO EXAMINER
Thursday, October 13, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 10, 2011NEW APPLICATION ENTERED IN TRAM